Back to Search Start Over

Comparison of T 1 Rho MRI, Glucose Metabolism, and Amyloid Burden Across the Cognitive Spectrum: A Pilot Study.

Authors :
Boles Ponto LL
Magnotta VA
Menda Y
Moser DJ
Oleson JJ
Harlynn EL
DeVries SD
Wemmie JA
Schultz SK
Source :
The Journal of neuropsychiatry and clinical neurosciences [J Neuropsychiatry Clin Neurosci] 2020 Fall; Vol. 32 (4), pp. 352-361. Date of Electronic Publication: 2020 Apr 14.
Publication Year :
2020

Abstract

Objective: The pathological cascades associated with the development of Alzheimer's disease (AD) have a common element: acidosis. T <subscript>1</subscript> rho MRI is a pH-sensitive measure, with higher values associated with greater neuropathological burden. The authors investigated the relationship between T <subscript>1</subscript> rho imaging and AD-associated pathologies as determined by available diagnostic imaging techniques.<br />Methods: Twenty-seven participants (men, N=13, women, N=14; ages 55-90) across the cognitive spectrum (healthy control subjects [HCs] with normal cognition, N=17; participants with mild cognitive impairment [MCI], N=7; participants with mild AD, N=3) underwent neuropsychological testing, MRI (T <subscript>1</subscript> -weighted and T <subscript>1</subscript> rho [spin-lattice relaxation time in the rotating frame]), and positron emission tomography imaging ([ <superscript>11</superscript> C]Pittsburg compound B for amyloid burden [N=26] and [ <superscript>18</superscript> F]fluorodeoxyglucose for cerebral glucose metabolism [N=12]). The relationships between global T <subscript>1</subscript> rho values and neuropsychological, demographic, and imaging measures were explored.<br />Results: Global mean and median T <subscript>1</subscript> rho were positively associated with age. After controlling for age, higher global T <subscript>1</subscript> rho was associated with poorer cognitive function, poorer memory function (immediate and delayed memory scores), higher amyloid burden, and more abnormal cerebral glucose metabolism. Regional T <subscript>1</subscript> rho values, when controlling for age, significantly differed between HCs and participants with MCI or AD in select frontal, cingulate, and parietal regions.<br />Conclusions: Higher T <subscript>1</subscript> rho values were associated with greater cognitive impairment and pathological burden. T <subscript>1</subscript> rho, a biomarker that varies according to a feature common to each cascade rather than one that is unique to a particular pathology, has the potential to serve as a metric of neuropathology, theoretically providing a measure for assessing pathological status and for monitoring the neurodegeneration trajectory.

Details

Language :
English
ISSN :
1545-7222
Volume :
32
Issue :
4
Database :
MEDLINE
Journal :
The Journal of neuropsychiatry and clinical neurosciences
Publication Type :
Academic Journal
Accession number :
32283991
Full Text :
https://doi.org/10.1176/appi.neuropsych.19100221